Get a load of ZIF! Better delivery of cancer immunotherapy
2021-02-11
(Press-News.org) Loading a cancer immunotherapy drug onto a metal organic framework improves both its delivery and its sustained release for treating leukemia. Furthermore, coating the drug-loaded framework with a cancer cell membrane improves targeted delivery to solid tumors. These findings could lead to safer and more reliable cancer immunotherapies.
"We believe our findings are quite significant because they show that the undesirable side effects of immunotherapy can be modulated by choosing the right delivery vehicle," says KAUST chemist Niveen Khashab. "They also show that targeted delivery can be realistically established through proper surface functionalization."
Cancer immunotherapy involves using drugs that modulate the immune system to make it more effective in attacking tumors. Nivolumab is one such drug, which counteracts a cancer immune evasion strategy that involves expressing PD-L1 molecules that deactivate T cells by blocking the PD-1 molecules on their surfaces.
Yet nivolumab, like other "immune checkpoint inhibitors", can cause immune-related adverse effects, where excessive T cell activation leads to an immune response against the recipient's organs. Scientists are looking for ways to improve the delivery of antibodies like nivolumab so that their release is slow, sustained and targeted, with minimal adverse effects.
Khashab's group worked with a metal organic framework called zeolitic imidazolate (ZIF-8), a crystalline solid formed of zinc ion subunits attached to organic methylimidazole. "ZIF-8 nanoparticles have shown great potential in cancer drug delivery in the last few years," says Somayah Qutub, a Ph.D. student in Khashab's group. "They are composed of zinc ions and imidazole, which are naturally found in the body." This makes the biocompatible, biodegradable and highly porous nature of ZIF-8 ideal for the safe loading and delivery of drugs like nivolumab.
Khashab's team loaded nivolumab onto ZIF-8 and tested its effects on leukemia cells. They found that the antibody was slowly released from the ZIF-8 framework when in proximity to a slightly acidic tumor microenvironment. This process prevents the T cells from being deactivated by cancerous cells so that they can attack the leukemia cells.
The team also tested the system for delivering the antibody to solid tumors both in Petri dish experiments and in mice. They encapsulated nivolumab-loaded ZIF-8 with the membrane of the cancer cells that were being targeted. This led to the accurate delivery of the system to the tumor, followed by slow and sustained drug release. Importantly, the mice showed negligible toxicity from the drug, which significantly inhibited tumor growth and prolonged survival.
"Our next step is to improve this system," says Qutub. "We are combining immunotherapy drugs with other anti-cancer modalities to have a synergic effect. We are also working on optimizing our cancer cell membrane coating with other materials so that the system can be easily reproducible, scalable and compatible with biopharmaceutical industry standards."
INFORMATION:
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-11
The energy of the future lies in the area of the controlled thermonuclear fusion. The scientific group from Peter the Great St.Petersburg Polytechnic University (SPbPU), headed by Professor Vladimir Rozhansky, is directly involved in the establishment of the world's largest experimental thermonuclear reactor ITER. Researchers discovered new effects, which affect the energy flow in the reactor. The theoretical predictions were confirmed by the experiments on two tokamaks. The research results were published in the scientific journal "Plasma Physics and Controlled Fusion".
The scientific group of Polytechnic University is engaged in modeling of the edge plasma. The researchers aim to identify how and ...
2021-02-11
In the early days of the COVID-19 pandemic, it was established that SARS-CoV-2 infects cells by binding to the human protein ACE2, which plays a role in regulating blood pressure. But ACE2 is almost absent in human lung cells, so how can the lungs be one of the most affected organs in COVID-19? This gave researchers a hint that ACE2 might be more than just a blood pressure regulator, and might not be the only player in the SARS-CoV-2 infection mechanism.
EMBL's Gibson team, in collaboration with Lucía Chemes at Universidad Nacional de San Martín in Buenos Aires and ...
2021-02-11
Research from the Business School (formerly Cass) suggests that observing others' decision-making can teach people to make better decisions themselves.
The research, co-authored by Professor Irene Scopelliti, Professor of Marketing and Behavioural Science, tested the effectiveness of a new debiasing training strategy and reports first evidence that watching others make decisions can improve our own decision making.
The authors carried out three experiments, which involved participants making a set of judgements before and after a training intervention designed to improve their decision-making.
Experiment ...
2021-02-11
A study led by researchers at Lund University in Sweden showed a connection between lifestyle intervention in pregnant women with obesity and epigenetic alterations in the baby. The study is published in the journal Diabetes.
An international collaboration between researchers in Sweden, Denmark and Spain investigated whether children's genes were programmed differently if a pregnant woman with a BMI over 30 underwent lifestyle interventions.
The study involved 425 pregnant women, all of whom have a BMI over 30, which is defined as obesity. They were divided at random into three different groups:
Group 1 had a lifestyle intervention that included both physical activity (they were urged to walk 11 000 steps per day and use a step counter) and a ...
2021-02-11
Those with asthma are experiencing less asthma control related to an increase in using household disinfectants -- known asthma triggers -- because of COVID-19, according to a survey co-conducted by University of Illinois Chicago researchers.
"We became concerned with increased cleaning and disinfecting related to the COVID-19 pandemic, combined with people spending more time indoors may expose people with asthma to more environmental triggers for asthma symptoms," Eldeirawi said. "This prompted our interest in studying the impact of disinfectants and asthma control among those living with asthma."
Cleaning products are considered respiratory irritants that cause inflammation and bronchial hyperresponsiveness, Eldeirawi explained. ...
2021-02-11
American athlete Tom Brady has done the seemingly impossible, winning his seventh Super Bowl at the age of 43 in spectacular fashion. He's joined by stellar company: At 39, Serena Williams has won 23 grand slams, one of them while pregnant.
The reasons for age-defying athletic performances are dependent on numerous factors, including diet, but a new study by Iranian and University of South Australia researchers shows that when it comes to track and field events, the age when athletes peak often depends on the sport.
Discus and javelin throwers as well as marathon runners and race walkers are likely to achieve their best performances at a later age than sprinters, hurdlers and ...
2021-02-11
Australian researchers have come up with two key recommendations from studies of the annual influenza season - one highlighting the benefits of antivirals in reducing repeat hospitalisation, and the other to watch for underlying cardiovascular disease.
While the world focuses on the rising COVID-19 death toll, seasonal influenza continues to cause significant mortality and poses a significant economic burden every year.
The South Australian study, conducted at two major metropolitan training hospitals between January 2016 and March 2020, collected data from 1,828 adult patients (average age around 66) who were hospitalised with influenza A and B.
Researchers compared outcomes for patients who did and did not take the antiviral ...
2021-02-11
On February 19, the world's second-largest greenhouse gas emitter, the United-States, will rejoin the Paris Agreement. This will kickstart a year of intensifying policy activity ahead of the United Nations Climate Change conference (COP26) in November, when countries will re-commit to their emissions reduction goals.
"The early signs are that 2021 could be the most important year for action on climate change since 2015," says Aengus Collins, deputy director of EPFL's International Risk Governance Center (IRGC). "A growing number of countries and organisations are committing to ambitious decarbonisation goals. The pace is picking up and it is crucial not to let progress be derailed."
The most pressing ...
2021-02-11
LOS ANGELES -- Some 15% of couples struggle with infertility. When couples fail to conceive, guidelines recommend both the man and woman undergo a tandem fertility evaluation.
For men, this includes providing at least one semen sample, which is analyzed to determine if there are factors reducing the sperms' chances of fertilizing an egg.
The current gold standard of sperm fertility evaluation requires men to provide a sperm sample in a lab or clinic, which is then examined within an hour. After an hour, the sperm begin to die, and the results are no longer accurate.
However, a new END ...
2021-02-11
One of the most abundant bats in Europe may be attracted to wind turbines, a new study shows.
The activity of common pipistrelle bats was monitored at 23 British wind farms and similar "control" locations close by without turbines.
Activity was around a third higher at turbines than at control locations, and two thirds of occasions with high activity were recorded at turbines rather than the controls.
The reasons for this are not clear. Possibilities include attraction to the turbines themselves, or the presence of more of the bats' insect prey around turbines.
"Either way it means the risk of fatality at wind turbines is increased, and probably explains the high fatalities of common ...
LAST 30 PRESS RELEASES:
[Press-News.org] Get a load of ZIF! Better delivery of cancer immunotherapy
